To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min EndoQuest's flexible endoscopy ...
EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced new initiatives as part of their collaboration with NVIDIA to integrate NVIDIA IGX Thor, an ...
Houston, TX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced it is integrating NVIDIA IGX Thor, a NVIDIA ...
EndoQuest Robotics Secures Series D-2 Funding Round co-led by Crescent Enterprises and Dr. Fred Moll
Houston, TX, July 14, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, announced today that it has successfully closed a Series D-2 ...
EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals in early 2025 Houston, TX, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The US Food and ...
A Mayo Clinic gastroenterologist has completed the first procedure in EndoQuest Robotics’ trial of its endoluminal surgical system. Norio Fukami, MD, removed a colorectal lesion using the robotic ...
Houston, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced the completion of the first procedure ...
U.S. FDA grants approval to complete enrollment in EndoQuest’s ongoing PARADIGM Trial following the clinical study’s favorable interim safety review Dr. Eric Haas performing the PARADIGM Trial’s first ...
EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a robotic endoluminal system for gastrointestinal procedures. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results